Upregulated mRNA expression of mTOR in surgically resected early stage non-small cell lung carcinoma: a potential molecular targeted therapy
Journal Title: Current Thoracic Surgery - Year 2017, Vol 2, Issue 1
Abstract
Background: Non-small cell lung cancer (NSCLC) comprises about 85% of all lung cancers. Although many attempts for early detection and treatment, prognosis of NSCLC is still poor. In recent years the pathways and the genes that play role in lung cancer development were researched widely. PI3K/AKT/MTOR which is thought to be efficacious in the development of many cancer which controls the expression of many genes playing an important role in cell proliferation, metastasis, resistance to apoptosis and angiogenesis. Also the increase in CCND1 expression was shown in several cancer types. The aim of this study is to search the mRNA expression profile of AKT, MTOR and CCND1 genes which has been thought to play role in NSCLC development, and their expression in different pathological stages and histological types of the disease. Materials and Methods: Forty-four NSCLC patients who didn’t get neoadjuvant therapy were included in this study. The samples from tumor and matched normal lung tissue were obtained from resection specimens (lobectomy or pneumonectomy). Total cellular RNA was isolated from the samples. The mRNA expression levels of AKT1, mTOR and CCND1 genes were measured by quantitative real-time polymerase chain reaction (qPCR). Results: Our findings revealed a statistically significant increase of mTOR expression on mRNA levels (P < 0.05). Although AKT and CCND1 expression slightly increased in malign tissues, these changes in the expression were not significant (P > 0.05). The mRNA expression of mTOR was also upregulated and it was statistically significant for early stage disease and adenocarcinoma subtype (P < 0.05). Conclusions: Inhibition of mTOR gene expression at mRNA level might be potential target for future treatment strategies of NSCLC.
Authors and Affiliations
Muhammet Sayan, Ali Çelik, Şevki Mustafa Demiröz, Hacer İlke Önen, Nalan Akyürek, Ece Konaç, İsmail Cüneyt Kurul, Abdullah İrfan Taştepe
Keywords
Related Articles
- EP ID EP292654
- DOI 10.26663/cts.2017.0002
- Views 79
- Downloads 0
Current status of tracheal tissue engineering
Management of large airway defects is challenging for clinicians due to lack of effective treatment modalities and eventually interest has turned to the field of airway tissue engineering. Considerable progress has been...
Granulomatous disease in patients operated due to provisional diagnosis of lung cancer
Background: The granulomatous reaction is a response that can occur in many infective, toxic, allergic, autoimmune, neoplastic, and etiologically unknown conditions. Hundreds of different agents that can cause this respo...
Is chest x-ray necessary after thoracentesis? Bilateral pneumothorax
Currently, thoracentesis is used to drain accumulated fluids in chest cavity such as; pleural effusion, hemothorax and chylothorax and also for diagnosis and treatment of diseases. It is a simple and reliable treatment m...
Diagnosis and treatment of spontaneous pneumomediastinum is not complicated
Background: Spontaneous pneumomediastinum is a rare and usually benign finding in young male patient without a history. When subcutaneous emphysema occurs, the patient and medical physicians feel uneasy about the view of...
Chest wall deformities and coincidence of additional anomalies, screening results of the 25.000 Turkish children with the review of the literature
Background: The main subtypes of chest wall deformities are pectus excavatum (PE) and pectus carinatum (PC). Although these are not life threatening diseases, some functional or physico-social disabilities due to the abn...